Brain metastases (BM) from extracranial cancer are associated with significant morbidity and
mortality. Effective local treatment options are stereotactic radiotherapy, including …

A previous review published in 2012 demonstrated the role of clinical PET for diagnosis and
management of brain tumors using mainly FDG, amino acid tracers, and 18 F …

The investigation of cerebral metabolic rate of glucose (CMRGlu) at baseline and during
specific tasks previously required separate scans with the drawback of high intrasubject …

The actual role of 18F-FDG PET/CT in evaluating primary brain lymphoma is still an open
issue. Brain lymphoma usually show elevated 18F-FDG uptake, often higher than other …

[18F] tetrafluoroborate ([18F] TFB) is an emerging PET tracer with excellent properties for
human sodium iodide symporter (NIS)–based imaging in patients with differentiated thyroid …

Abstract Background 18Fluorine-Fluoro-deoxy-glucose (18F-FDG) positron emission
tomography (PET) is widely used for diagnosing various malignant tumors and evaluating …

Background Primary central nervous system lymphoma (PCNSL) and high-grade glioma
(HGG) appear similar under imaging. However, since the two tumors vary in their treatment …

OBJECTIVE. FDG PET/CT of brain tumors is limited by background activity. Dual-phase FDG
PET/CT can eliminate this limitation and allow discernment of viable tumors. Our aim was to …

Simple Summary Brain metastases have an important clinical impact, particularly in terms of
treatment and quality of life for cancer patients. Despite the fact that MRI is the imaging …

PET holds potential to provide additional information about tumour metabolic processes,
which could aid brain tumour differential diagnosis, grading, molecular subtyping and/or the …